US Archives - Page 15 of 119 - European Medical Journal

Enhancing Cancer Care Through Vaccines

Patients with cancer often have a compromised immune system, which places them at an increased risk of infection that can extend beyond…

Advances in HER2-Mutant NSCLC

Mutations in HER2, also known as ERBB2, represent a distinct molecular subset of NSCLC, occurring in approximately 2–4% of cases, and are…

Targeting DLL3 in Rare Neuroendocrine Carcinoma

EpNECs are considered rare and are often associated with a poor prognosis, with up to 85% of patients presenting with advanced…

The Two Faces of Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is frequently diagnosed at an advanced stage, when most patients have underlying cirrhosis. Prognosis is…

AMJ Oncology 2.1 2025

Explore the latest issue of AMJ Oncology, featuring expert insights from American Society of Clinical Oncology (ASCO) 2025, new research…

Neoadjuvant Therapy in TNBC: Current Landscape and Emerging Therapies

Triple-negative breast cancer (TNBC) comprises 10–15% of all breast cancers. It is a very heterogeneous disease, characterized by the…

The latest edition of AMJ Oncology

Uncover everything you need to know from this year’s ASCO congress and beyond in our new Oncology journal, featuring the latest highlights…

American Society of Clinical Oncology (ASCO) Annual Meeting 2025 Highlights

Optimizing Board Exam Outcomes For Hematology/Oncology Fellows

Certification in Hematology and Oncology requires mastery of increasingly complex clinical knowledge. Despite this, approximately 8% of…

ASCO 2025: Driving Knowledge to Action in Cancer Care

THE 2025 American Society of Clinical Oncology (ASCO) Annual Meeting underscored a key principle: in today’s complex and rapidly…